Just burying the plant's lead.
No biotech with a quarter billion in cash, no debt, paying a dividend and announcing a share buyback program will be raising capital through stock issuance.
I am buying shares aggressively.
Back out the $4.70 in cash and the value of all Clinuvel's amazing opportunities is $6. Beyond ridiculous.
The P/E is 8. PEG about .67.
Beyond ridiculous.
Either we have the most undervalued company I've seen in 30 years of investing, or we have an elaborate Matchstick Men level scam. The risk/reward is a no brainer in my opinion.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$10.69 |
Change
0.030(0.28%) |
Mkt cap ! $535.3M | |||
| Open | High | Low | Value | Volume |
| $10.80 | $10.80 | $10.55 | $832.5K | 77.93K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 404 | $10.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.70 | 1373 | 11 |
View Market Depth
| Last trade - 13.58pm 12/09/2025 (20 minute delay) ? |
| CUV (ASX) Chart |